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A
CDbstruction resolves. Patients do not generally require life-
ong -blocker therapy. If LVOTO resolves, -blockers
ay be weaned with follow-up echocardiograms 3 months
ater. Those who have SAM without LVOTO may be fol-
owed clinically at the discretion of a cardiologist unless
here is a change in the patients’ functional status or a new
r changing murmur develops, at which point a repeat
chocardiogram would be prudent.
SAM is an important cause of mitral regurgitation early
fter valve repair. Identification and proper treatment with
-blockade and avoidance of afterload-reducing medica-
ions are usually successful, and re-repair is rarely neces-
ary. However, if medical management fails to improve
itral regurgitation, surgeons must be willing to undertake
perative revision of the mitral valve repair.
The late outcomes in this series (no mortality and 90% of
atients in NYHA class I at late follow-up) support the
trategy of nonsurgical treatment of SAM with or without
VOTO.
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iscussion
r James I. Fann (Stanford, Calif). Dr Brown, I first want to
ongratulate you on an interesting and comprehensive presenta-
ion. It is always valuable to reevaluate one’s experience with a
ifficult complication after what otherwise should be a gratifying
rocedure.
You and your colleagues have provided an analysis of over
000 patients in a 10-year period and confirmed that SAM after
itral valve repair occurs in a small fraction of patients. As you
entioned, for those at risk for SAM, mainly those with myxo-
atous disease and prolapse, the incidence is 11%. What is of
ore interest and clinical challenge are those patients with outflowract obstruction, which occurred in 34 patients, or to put it another
ary 2007
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A
CDay, in 2% of all patients in the series. Your approach to treatment
as medical with volume infusion, -blockade, vasoconstriction,
nd cessation of inotropic agents. I agree with this approach,
lthough there are times when during the postoperative manage-
ent and the patient is not doing so well that perhaps it might have
een easier to have done an adjunctive procedure after establishing
he diagnosis of outflow tract obstruction. Do you think a more
ggressive approach should be used in the subset of patients with
utflow tract obstruction?
Dr Brown. Among our patients, there were 34 who had
VOTO. The gradients that were recorded during the operating
oom ranged between 20 and 64 mm Hg. We found that in general,
here was no trend indicating that these patients required reopera-
ion or had any other complication. They responded well to med-
cal management, and we do not think this is a contraindication to
edical management.
Dr Fann. That is reassuring. Not only is early diagnosis of this
omplication and institution of treatment important, but perhaps
e could determine the potential for developing SAM on the basis
f preoperative or intraoperative studies. Although your analysis is
etrospective, on the basis of your review of the echocardiographic
ata, can you comment on what findings may lead one to think that
AM is more likely? I’m referring to the utility of some proposed
easurements such as the length of the coapted anterior and
osterior leaflets, the ratio of the anterior and posterior leaflet
engths, the distance of the leaflet coaptation point to the septum,
nd the asymmetry of the anterior leaflet.
Dr Brown. Mayo Clinic published an abstract that looked at
rospective echocardiographic predictors. We have not found
hem, as well as other published predictors, to be clinically useful.
ecause these patients do well with medical management, we
enerally do not do any preventative techniques for SAM during
he original repair.
Dr Fann. When Dr Zehr was at Mayo Clinic, he described the
ransfer of the posterior secondary chordae to the underside of the
idanterior leaflet, thereby keeping the anterior leaflet away from
he outflow tract. He implied that there are patients at higher risk
or SAM, specifically those with billowing, redundant, or myxo-
atous anterior leaflet with a near-normal–sized left ventricle and
otentially hyperdynamic function. Were his patients included in
our analysis, and can you give any insight into whether you think
his or other adjunctive procedures, such as anterior leaflet valvu-
oplasty, may be of benefit?
Dr Brown. To your first question, Dr Zehr, who has unfortu-
ately left Mayo Clinic, and all surgeons who performed mitral
alve surgery within the time period of the study were included. b
The Journal of Thoracichere were no exclusions based on surgeon. Second, in terms of
he actual technique, many people have described various prophy-
actic surgical methods to prevent SAM. None of these have been
ble to show absolute prevention of SAM. In general, because of
he success of our medical management, we do not routinely use
hese surgical treatments.
Dr Fann. In those who developed SAM, 8 patients had under-
one valve repair that included placement of an Alfieri stitch at the
nitial procedure. This procedure, as you know, has been used to
orrect SAM with outflow tract obstruction. Can you explain how
hese patients developed SAM after placement of an Alfieri stitch
t the original operation?
Dr Brown. Yes, we had 8 patients who had an Alfieri stitch
ho went on to develop SAM. We are aware that an Alfieri or an
dge-to-edge technique has been reported in the literature as a
urgical treatment for SAM once it has developed. In all of these
atients, however, the Alfieri stitch was used to achieve a compe-
ent mitral valve and was not used for the purposes of SAM. We
hink that SAM may develop in these patients, as in our series;
owever, they, and all the other patients, responded well to the
edical management that was instituted.
Dr Fann. What is interesting is that the majority of patients
ad a partial flexible annuloplasty ring, that is, in those who
eveloped SAM, 99% of the patients had such an initial pro-
edure. In 2 patients who required revision, removal of the
nnuloplasty ring resolved the SAM. I find this interesting, and
t suggests that the ring placement or sizing might have been the
ulprit. One recommended method of sizing is to size the
nterior leaflet and not the inter-trigonal distance. Were you
ble to identify any particular method of ring sizing with regard
o the use of a partial annuloplasty ring that could decrease the
otential for SAM?
Dr Brown. I think it’s important to emphasize the fact that only
patients required removal of the band and had resolution of their
AM. The remaining patients did well with medical management.
n terms of the most common surgical technique performed at
ayo Clinic for mitral valve repair, in general and more recently,
posterior leaflet resection with an unmeasured 6.3-cm annulo-
lasty band is placed.
Dr Fann. Finally, it is important to emphasize that although it
s possible for late valve failure in these patients, development of
AM with outflow tract obstruction years later (as reported by
thers) is an unusual complication, and none of the patients re-
uired a later intervention for SAM in your series. Also, it should
e reiterated that close medical follow-up is critical.
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